Incidence of bacteriologically confirmed recurrences during 12-month follow-up
| Incidence of bacteriologically confirmed recurrences (days) | HA+CS (%) | Standard care (%) | p Value |
|---|---|---|---|
| 0–90 | 15.3 | 12.7 | 0.610 |
| 91–180 | 15.6 | 12.9 | 0.628 |
| 181–240 | 10.7 | 3.7 | 0.132 |
| 241–365 | 16.3 | 30.8 | 0.043 |
HA+CS, hyaluronic acid and chondroitin sulfate.